FDA Approval History
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA). Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest drug approvals
- Jobevne (bevacizumab-nwgd) - April 09, 2025
- Vanrafia (atrasentan) - April 02, 2025
- Qfitlia (fitusiran) - March 28, 2025
- Vykat XR (diazoxide choline) - March 26, 2025
- Blujepa (gepotidacin) - March 25, 2025
- Bomyntra (denosumab-bnht) - March 25, 2025
- Conexxence (denosumab-bnht) - March 25, 2025
- Gozellix (gallium Ga 68 gozetotide) - March 20, 2025
- Arbli (losartan potassium) - March 13, 2025
- Omlyclo (omalizumab-igec) - March 07, 2025
- Encelto (revakinagene taroretcel-lwey) - March 05, 2025
- Osenvelt (denosumab-bmwo) - February 28, 2025
- Stoboclo (denosumab-bmwo) - February 28, 2025
- Miudella (copper) - February 24, 2025
- Ctexli (chenodiol) - February 21, 2025
- Merilog (insulin aspart-szjj) - February 14, 2025
- Penmenvy (meningococcal groups A, B, C, W, and Y vaccine) - February 14, 2025
- Romvimza (vimseltinib) - February 14, 2025
- Vimkunya (chikungunya vaccine, recombinant) - February 14, 2025
- Ospomyv (denosumab-dssb) - February 13, 2025